RNS

27 July 2021

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

Plant Health Care Announces Exclusive Distribution of Harpin ab in the UK

Plant Health Care^® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce a new distribution agreement with a leading distributor in the UK for exclusive access to the biostimulant Harpin αβ in all crops in the UK.

Highlights

·    Harpin αβ has been shown to have exceptional grower benefits in the UK, particularly in the amenity (turf) market and in potatoes. 

·    Plant Health Care has reached an exclusive agreement with Agrii, a market-leading distributor in the UK.

Harpin αβ works by triggering the plant's own self defense systems, leading to a robust physiological response, in a manner similar to vaccinations in humans. The plant responds with improved crop quality, nutrient use efficiency, tolerance to abiotic stress and ultimately, increased marketable yield.

Harpin αβ has been sold on a small scale in the UK for 14 years, under the brand name ProAct^®.  Plant Health Care has been working with Agrii, a market-leading distributor in the UK, for several years to establish the grower benefits of Harpin ⍺β.  Results have been particularly exciting in the amenity sector and in potatoes.  The partner and Plant Health Care have therefore reached an agreement under which the partner will have exclusive distribution of Harpin αβ in the UK.

In the amenity sector, both leading golf courses and well-known football clubs are now using Harpin αβ to improve the quality of their turf.   

ProAct was launched into the potato market in 2019, where it has shown to increase the number of tubers per plant, increase marketable yield and to improve Calcium uptake for better storage.​

Jeff Tweedy, COO of Plant Health Care noted: " "We have been working on the technical benefits of Harpin αβ in the UK for some years.  We now have clarity on the best opportunities for the product.  This agreement with Agrii reflects our joint confidence in the growth of ProAct® sales in the UK, especially as UK farming drives towards increased sustainability.  We expect to see greater demand for biological solutions in the UK and it is exciting that this distribution agreement will mean more growers can access the yield improvement and sustainability benefits ProAct® offers.  This new agreement is also an important step towards building a stronger presence for Plant Health Care in Europe, which is the world's largest market for sustainable agriculture."  

For further information, please contact:

Plant Health Care plc

Chris Richards, CEO, Tel: +1 919 926 1600

Arden Partners plc - Nomad & Broker

John Llewellyn-Lloyd / Antonio Bossi Tel: +44 (0) 20 7614 5900

Company website: www.planthealthcare.com

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.